Arginyl-Glutamine

• UNSPSC Description:

  Arginyl-Glutamine is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy[1].

• Target Antigen:

  VEGFR

• Type:

  Peptides

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/arginyl-glutamine.html

• Solubility:

  10 mM in DMSO

• Smiles:

  N=C(N)NCCC[C@H](N)C(N[C@H](C(O)=O)CCC(N)=O)=O

• Molecular Weight:

  302.33

• References & Citations:

  [1]Neu J, et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3151-5.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2483-17-2